Scarica l'app Stockscreener
5.93
0.34%
-0.02
Dopo l'orario di chiusura:
5.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NEOG Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.95
Aprire:
$6.08
Volume 24 ore:
4.09M
Relative Volume:
0.67
Capitalizzazione di mercato:
$1.29B
Reddito:
$912.20M
Utile/perdita netta:
$-23.53M
Rapporto P/E:
-51.57
EPS:
-0.115
Flusso di cassa netto:
$-124.88M
1 W Prestazione:
-12.54%
1M Prestazione:
+12.52%
6M Prestazione:
+28.91%
1 anno Prestazione:
-59.41%
Intervallo 1D:
$5.83
$6.195
Intervallo di 1 settimana:
$5.74
$6.885
Portata 52W:
$3.8701
$16.79
Neogen Corp Stock (NEOG) Company Profile
Nome
Neogen Corp
Settore
Industria
Telefono
(517) 372-9200
Indirizzo
620 LESHER PLACE, LANSING
Confronta NEOG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NEOG
Neogen Corp
|
5.93 | 1.28B | 912.20M | -23.53M | -124.88M | -0.115 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Neogen Corp Stock (NEOG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-29 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-12-19 | Iniziato | Guggenheim | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-11-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2017-12-05 | Ripresa | ROTH Capital | Neutral |
| 2017-07-14 | Iniziato | CL King | Neutral |
| 2014-06-05 | Iniziato | William Blair | Mkt Perform |
| 2011-03-31 | Aggiornamento | Hilliard Lyons | Underperform → Neutral |
| 2009-09-25 | Reiterato | Roth Capital | Buy |
| 2009-07-22 | Reiterato | Roth Capital | Buy |
| 2009-03-20 | Reiterato | Roth Capital | Buy |
| 2009-01-07 | Reiterato | Roth Capital | Buy |
| 2008-09-25 | Reiterato | Roth Capital | Buy |
| 2008-01-04 | Reiterato | Roth Capital | Buy |
| 2007-09-28 | Reiterato | Roth Capital | Buy |
| 2007-07-25 | Reiterato | Roth Capital | Buy |
| 2007-07-09 | Reiterato | Roth Capital | Buy |
| 2007-05-08 | Iniziato | Susquehanna Financial | Positive |
Mostra tutto
Neogen Corp Borsa (NEOG) Ultime notizie
How cyclical is Neogen Corporation (NG2) stock compared to rivalsLong Setup & Risk Controlled Swing Alerts - newser.com
Piper Sandler Raises Price Target for NEOG to $6.50, Maintains N - GuruFocus
5 Revealing Analyst Questions From Neogen’s Q3 Earnings Call - Yahoo Finance
Blair William & Co. IL Decreases Stock Position in Neogen Corporation $NEOG - MarketBeat
Neogen Corp. Stock Hits Day Low of $5.57 Amid Price Pressure - Markets Mojo
Neogen : Transcript (2025 10 09 transcript fy26q1 earnings) - MarketScreener
Technical analysis overview for Neogen Corporation stock2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Price momentum metrics for Neogen Corporation explainedTrade Exit Summary & Weekly High Potential Alerts - newser.com
Inspire Investing LLC Acquires 46,753 Shares of Neogen Corporation $NEOG - MarketBeat
Neogen (NASDAQ:NEOG) Releases Earnings Results, Beats Expectations By $0.12 EPS - MarketBeat
Neogen (NASDAQ:NEOG) Shares Gap UpWhat's Next? - MarketBeat
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - Yahoo Finance
Neogen (NEOG): Losses Deepen 90.4% Annually, Market Discounts Turnaround Narrative - Yahoo Finance
Stock Traders Buy Large Volume of Call Options on Neogen (NASDAQ:NEOG) - MarketBeat
Neogen's (NEOG) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs - Yahoo Finance
NEOG Q3 Deep Dive: Q3 Results, Guidance Reaffirmed, and Operational Turnaround in Focus - The Globe and Mail
Decoding Neogen Corp (NEOG): A Strategic SWOT Insight - GuruFocus
Neogen: Fiscal Q1 Earnings Snapshot - Connecticut Post
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Animal Tester Neogen Sticks To Annual Forecast Despite TariffsNeogen (NASDAQ:NEOG) - Benzinga
Why Neogen (NEOG) Stock Is Trading Up Today - Yahoo Finance
Neogen Corp reports results for the quarter ended August 31Earnings Summary - TradingView
Neogen (NEOG) Q1 2026 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Neogen beats Q1 2026 earnings expectations - Investing.com
Neogen Outpaces Estimates But Faces Lower Sales After Divestiture - Finimize
Neogen Q1 Adj. EPS Meets Estimates; Reaffirms FY26 Revenue Outlook; Stock Up 8.6% - Nasdaq
Neogen (NEOG) Q1 Earnings Lag Estimates - Yahoo Finance
Neogen Q1 FY26 slides: revenue dips but company maintains full-year outlook - Investing.com
Neogen Corp (NEOG) Reports Q1 EPS of $0.17, Beating Estimates; R - GuruFocus
Neogen (NASDAQ:NEOG) Exceeds Q3 Expectations, Stock Soars - Yahoo Finance
Neogen shares soar 12% as first quarter results top expectations By Investing.com - Investing.com Canada
Neogen shares soar 12% as first quarter results top expectations - Investing.com
Neogen earnings beat by $0.11, revenue topped estimates - Investing.com
Neogen Corporation Q1 2026 Financial Results - TradingView
Neogen Announces First-Quarter 2026 Results - Yahoo Finance
Neogen (NEOG) Q3 Earnings Report Preview: What To Look For - Barchart.com
Could Neogen's (NEOG) Renewed Equestrian Partnership Reveal More About Its Animal Health Strategy? - Yahoo Finance
Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga
Neogen (NASDAQ:NEOG) Stock Price Down 6.4%Should You Sell? - MarketBeat
Can Neogen’s (NEOG) Renewed Equestrian Partnership Strengthen Its Position in Animal Health Solutions? - simplywall.st
Wall Street's Insights Into Key Metrics Ahead of Neogen (NEOG) Q1 Earnings - Yahoo Finance
Assessing Neogen (NEOG) Valuation After Recent Share Price Uptick - simplywall.st
Analysts Estimate Neogen (NEOG) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Neogen (NEOG) to Release Earnings on Thursday - MarketBeat
Neogen (NASDAQ:NEOG) Coverage Initiated at CJS Securities - MarketBeat
Neogen (NEOG): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Neogen (NEOG) Stock Trades Up, Here Is Why - Yahoo Finance
Will Neogen Corporation stock reach Wall Street targetsQuarterly Risk Review & Daily Risk Controlled Trade Plans - newser.com
Earnings visualization tools for Neogen CorporationOil Prices & Detailed Earnings Play Strategies - newser.com
Neogen Corporation (NASDAQ:NEOG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Neogen Corp Azioni (NEOG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neogen Corp Azioni (NEOG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Jones Douglas Edward | Former COO |
Oct 13 '25 |
Option Exercise |
6.04 |
783 |
4,729 |
89,241 |
| ADENT JOHN EDWARD | Former CEO |
Oct 13 '25 |
Option Exercise |
6.04 |
3,063 |
18,501 |
333,714 |
| Rocklin Amy M | Chief Legal Officer |
Oct 07 '25 |
Option Exercise |
5.36 |
9,036 |
48,433 |
53,206 |
| Jones Douglas Edward | Former COO |
Oct 07 '25 |
Option Exercise |
5.63 |
12,940 |
72,852 |
94,787 |
| ADENT JOHN EDWARD | Former CEO |
Oct 07 '25 |
Option Exercise |
5.63 |
32,936 |
185,430 |
339,948 |
| Woteki Catherine E | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
15,315 |
| Tobin James P | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
39,545 |
| RODRIGUEZ RAFAEL A | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
17,019 |
| Gupta Aashima | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
23,988 |
| Green Ronald D | Director |
Oct 07 '25 |
Option Exercise |
5.63 |
2,071 |
11,660 |
14,852 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):